OmniBind: Proteome-Wide Promiscuity Predictions for Early-Stage Drug Screening
Hanke, J.; Pujalte Ojeda, S.; Cheong, R. W.; Glasstetter, L. M.; Baker, E.; Lam, H. Y. I.; Brezinova, M.; Louet, A. A. B.; Zhang, S.; Vendruscolo, M.
Show abstract
Off-target binding remains a leading cause of drug attrition, yet no method exists for rapidly quantifying small-molecule promiscuity across the human proteome. Here, we define promiscuity as the mean predicted binding affinity over 15,405 human proteins and derive a specificity score combining target affinity with this proteome-wide distribution. To make this assessment tractable at scale, we introduce OmniBind, a message-passing neural network that predicts promiscuity directly from a SMILES string at about a thousand compounds per second, several orders of magnitude faster than proteome-wide profiling. OmniBind promiscuity scores correlate with experimental binding data near assay reproducibility limits. Ranking candidates by specificity rather than affinity alone improves enrichment of approved drugs across all thresholds tested, an advantage robust to the choice of affinity predictor. OmniBind fills an unoccupied niche in the early-stage screening landscape as a fast, proteome-scale complement to traditional safety panels, with accuracy that will scale as the underlying affinity predictors continue to improve.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Decoding efficacy and resistance space at a drug binding site 95%
- Machine Learning Identifies Novel Candidates for DrugRepurposing in Alzheimer's Disease 95%
- Multiplexed single-cell profiling of post-perturbation transcriptional responses to define cancer vulnerabilities and therapeutic mechanism of action 94%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Large Scale Cell Painting Guided Compound Selection Reveals Activity Cliffs and Functional Relationships 96%
- The pharmacoepigenomic landscape of cancer cell lines reveals the epigenetic component of drug sensitivity 93%
- Multiparametric quantitative phase imaging for real-time, single cell, drug screening in breast cancer 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.